Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
Recruiting now
Conditions studied: Pelvic Organ Prolapse, Stage III and IV High Grade Pelvic Organ Prolapse
In brief
This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.
Key facts
- Study ID
- NCT05682989
- Run by
- Mackay Medical College
- People needed
- 150
- Starts
- 2022-08-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2023-04-05
Who can join
Age: 30 and older, up to 100. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Pelvic organ prolapse patients with objective / subjective voiding dysfunctions
- Underwent surgery for symptomatic POP ≥ stage II (POP-Q system)
You may not qualify if…
- Patients with a history of pelvic radiation.
- Patients with a history of vesico-/recto-/urethra-vaginal fistula
- Patients unable to be followed up.
Where it is running
- Department of Obstetrics and Gynecology — New Taipei City, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.